Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis

A Post-Marketing Surveillance For Safety And Adherence To Treatment Of Enbrel In Adults With Psoriatic Arthritis In Belgium

The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteria.

Inclusion Criteria:

• Active erosive psoriatic arthritis of poly-articular type or active erosive or with joint space narrowing psoriatic arthritis of oligo-articular type
• At least 18 years old
• Have fulfilled reimbursement criteria for Enbrel in psoriatic arthritis of poly-articular type or oligo-articular type
• Physician decides to prescribe Enbrel or patient is already on Enbrel
• Give written informed consent at time of inclusion to study

Exclusion Criteria:

NA